All News about Biogen Idec
![](https://cdn.benzinga.com/files/images/story/2023/03/21/biib.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/20/sgmo_logo_light__df15263084666d45f8f072d9581b42da.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/724874/gettyimages-1072035598.jpg)
![](/next-assets/images/schema-image-default.png)
Price Over Earnings Overview: Biogen
March 17, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
(BIIB) - Analyzing Biogen's Short Interest
March 17, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/16/biib.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/16/dementia-3051832_1920.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Biogen's Debt Overview
March 15, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/724292/doctor-and-patient-talking.jpg)
![](https://www.investors.com/wp-content/uploads/2018/11/Stock-DrugsPills-04-adobe.jpg)
![](https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg)
Biotech Sector Working Fast to Combat Alzheimer’s Disease Cases That are Set to Explode
March 15, 2023
Exposures
COVID-19
![](https://cdn.benzinga.com/files/images/story/2023/03/14/biib_1.png?width=1200&height=800&fit=crop)
![](https://www.marketbeat.com/logos/articles/small_20230314120936_monoclonal-antibodies-avid-bioservices-surges-32-o.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/03/13/sage.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2018/05/Stock-Lilly-01-Shutterstock.jpg)
![](https://investorplace.com/wp-content/uploads/2022/01/shutterstock_1938998998-1024x576.png)
![](https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg)
![](https://g.foolcdn.com/editorial/images/723638/doctor-with-senior-man_gettyimages-1147479334.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/03/06/biib_mark_dark__7632718edf7a3dc6bcc595f9c20d8b68.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_3910.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_3814.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg)
![](https://www.investors.com/wp-content/uploads/2019/01/Stock-Drugs-024-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/02/27/reta_mark_composite_dark__eafe68e3c8512c6e24db962cd28fafd1.png?width=1200&height=800&fit=crop)
![](https://cdn.pixabay.com/photo/2017/08/26/10/47/businessman-2682712__340.jpg)
![](https://www.marketbeat.com/logos/articles/small_20230222073259_3-mid-cap-biotechs-the-street-sees-doubling.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/02/17/gehc_mark_composite_dark__0de937d7b3e73511ca239b82c710ca8c.png?width=1200&height=800&fit=crop)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.